Activated T cells

Drug Profile

Activated T cells

Alternative Names: Xcellerated T Cells; XcyteDynabeads

Latest Information Update: 13 Oct 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Xcyte Therapies
  • Class T lymphocyte cell therapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Autoimmune disorders; Chronic lymphocytic leukaemia; Multiple myeloma; Non-Hodgkin's lymphoma; Prostate cancer; Renal cancer

Most Recent Events

  • 13 Oct 2005 Discontinued - Phase-I/II for Prostate cancer in USA (IV-infusion)
  • 13 Oct 2005 Discontinued - Phase-I/II for Renal cancer in USA (IV-infusion)
  • 13 Oct 2005 Discontinued - Preclinical for Autoimmune disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top